Blood Galectin-3 Levels Predict Postoperative Complications after Colorectal Cancer Surgery.
暂无分享,去创建一个
A. Matsuda | H. Yoshida | Y. Kawano | T. Matsutani | S. Matsumoto | M. Miyashita | K. Sekiguchi | T. Yamada | N. Sakurazawa | Marina Yamada | Nobuyuki Sakurazawa
[1] S. Shiozawa,et al. Worse Preoperative Status Based on Inflammation and Host Immunity Is a Risk Factor for Surgical Site Infections in Colorectal Cancer Surgery. , 2017, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[2] K. Stengaard-Pedersen,et al. Galectin‐3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti‐CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity , 2017, Scandinavian journal of immunology.
[3] D. McMillan,et al. A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer , 2017, Annals of Surgical Oncology.
[4] I. Dijkstra,et al. Postoperative Interleukin-6 Level and Early Detection of Complications After Elective Major Abdominal Surgery , 2016, Annals of surgery.
[5] T. Mueller,et al. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[6] D. McMillan,et al. Postoperative C-reactive protein measurement predicts the severity of complications following surgery for colorectal cancer , 2015, International Journal of Colorectal Disease.
[7] Peter J. Richardson,et al. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. , 2015, Annals of surgery.
[8] D. Jayne,et al. The Impact of Postoperative Complications on Long-term Quality of Life After Curative Colorectal Cancer Surgery , 2014, Annals of surgery.
[9] M. Sun,et al. Galectin-3 in cancer. , 2014, Clinica chimica acta; international journal of clinical chemistry.
[10] M. Netea,et al. Circulating galectin-3 in infections and non-infectious inflammatory diseases , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[11] D. Metzger,et al. Galectin-3 Functions as an Alarmin: Pathogenic Role for Sepsis Development in Murine Respiratory Tularemia , 2013, PloS one.
[12] Bertram Pitt,et al. Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis , 2013, Circulation. Heart failure.
[13] D. McMillan,et al. C-reactive Protein as a Predictor of Postoperative Infective Complications after Curative Resection in Patients with Colorectal Cancer , 2012, Annals of Surgical Oncology.
[14] M. Buljan,et al. Prognostic value of galectin‐3 in primary cutaneous melanoma , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.
[15] D. McMillan,et al. The Impact of Perioperative Risk, Tumor Pathology and Surgical Complications on Disease Recurrence Following Potentially Curative Resection of Colorectal Cancer , 2011, Annals of surgery.
[16] A. Mirnezami,et al. Increased Local Recurrence and Reduced Survival From Colorectal Cancer Following Anastomotic Leak: Systematic Review and Meta-Analysis , 2011, Annals of surgery.
[17] M. Hammam,et al. Diagnostic and Prognostic Role of Galectin 3 Expression in Cutaneous Melanoma , 2010, The American Journal of dermatopathology.
[18] J. Schölmerich,et al. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. , 2010, The Journal of clinical endocrinology and metabolism.
[19] H. Hillege,et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study , 2010, Clinical Research in Cardiology.
[20] L. Truong,et al. Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker. , 2010, Archives of pathology & laboratory medicine.
[21] A. Nesbakken,et al. Short term outcome after emergency and elective surgery for colon cancer , 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[22] H. Nielsen,et al. Diagnostic Accuracy of C-reactive Protein for Intraabdominal Infections After Colorectal Resections , 2009, Journal of Gastrointestinal Surgery.
[23] F. Mascart,et al. Expression of galectin-3 in the tumor immune response in colon cancer , 2008, Laboratory Investigation.
[24] Y. Mohri,et al. Continuous Follow-up of Surgical Site Infections for 30 Days After Colorectal Surgery , 2008, World Journal of Surgery.
[25] Y. Mohri,et al. Postoperative weight loss during hospital stays in patients with gastric cancer undergoing surgical resection. , 2008, Hepato-gastroenterology.
[26] K. Slim,et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study. , 2005, Archives of surgery.
[27] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[28] Jiang He,et al. Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke , 2018, Stroke.
[29] D. McMillan,et al. Examination of a CRP fi rst approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer A pragmatic study , 2017 .
[30] A. Matsuda,et al. Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. , 2012, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[31] M. Torzewski,et al. Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients , 2011, International Journal of Colorectal Disease.